Inventor · disambiguated record
Jason M. Vaughn
Also filed as: VAUGHN JASON · VAUGHN JASON M · VAUGHN JASON MICHAEL
18 granted patents·11 pending applications·181 citations·filing 2007–2025
94Inventor score
Files withBANNER LIFE SCIENCES LLC15VAUGHN JASON M4ARAGON PHARMACEUTICALS INC3PATHEON SOFTGELS INC3FLAMEL IRELAND LTD2
Top patents by PatentIndex Score
29 records- 0198US9820961B2Fumarate ester dosage formsBANNER LIFE SCIENCES LLC·Filed 2017·Granted Nov 21, 2017·26 cites·20 claims
- 0298US9814692B2Fumarate ester dosage formsBANNER LIFE SCIENCES LLC·Filed 2016·Granted Nov 14, 2017·27 cites·20 claims
- 0398US9636319B1Fumarate ester dosage formsBANNER LIFE SCIENCES LLC·Filed 2016·Granted May 2, 2017·26 cites·20 claims
- 0498US9636318B2Fumarate ester dosage formsBANNER LIFE SCIENCES LLC·Filed 2016·Granted May 2, 2017·28 cites·22 claims
- 0598US9566259B1Fumarate ester dosage formsBANNER LIFE SCIENCES LLC·Filed 2016·Granted Feb 14, 2017·26 cites·29 claims
- 0697US10105335B2Fumarate ester dosage formsBANNER LIFE SCIENCES LLC·Filed 2017·Granted Oct 23, 2018·11 cites·21 claims
- 0797US10098863B2Fumarate estersBANNER LIFE SCIENCES LLC·Filed 2017·Granted Oct 16, 2018·23 cites·23 claims
- 0893US10945985B2Fumarate ester dosage formsBANNER LIFE SCIENCES LLC·Filed 2018·Granted Mar 16, 2021·3 cites·13 claims
- 0992US9877971B2Soft lozenges comprising corticosteroidsBANNER LIFE SCIENCES LLC·Filed 2016·Granted Jan 30, 2018·7 cites·21 claims
- 1086US12303493B2Anticancer compositionsARAGON PHARMACEUTICALS INC·Filed 2024·Granted May 20, 2025·0 cites·30 claims
- 1183US9849125B1Anti-overingestion dosage formsBANNER LIFE SCIENCES LLC·Filed 2016·Granted Dec 26, 2017·2 cites·20 claims
- 1280US10195211B2Soft lozenge compositionsPATHEON SOFTGELS INC·Filed 2017·Granted Feb 5, 2019·1 cites·20 claims
- 1380US10188662B2Soft lozenge compositionsPATHEON SOFTGELS INC·Filed 2017·Granted Jan 29, 2019·1 cites·20 claims
- 1478US11590095B2Fumarate ester dosage formsBANNER LIFE SCIENCES LLC·Filed 2021·Granted Feb 28, 2023·0 cites·19 claims
- 1576US2023233529A1Anticancer compositionsARAGON PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1671US2008075771A1Hydrophilic opioid abuse deterrent delivery system using opioid antagonistsVAUGHN JASON M·Filed 2007·Application pending·0 cites
- 1771US2008075770A1Hydrophilic abuse deterrent delivery systemVAUGHN JASON M·Filed 2007·Application pending·0 cites
- 1867US2010047345A1Hydrophobic abuse deterrent delivery system for hydromorphoneCROWLEY MICHAEL M·Filed 2009·Application pending·0 cites
- 1966US10918615B2Fumarate estersBANNER LIFE SCIENCES LLC·Filed 2018·Granted Feb 16, 2021·0 cites·12 claims
- 2062US2008020032A1Hydrophobic abuse deterrent delivery system for hydromorphoneCROWLEY MICHAEL·Filed 2007·Application pending·0 cites
- 2162US2008075768A1Hydrophobic opioid abuse deterrent delivery system using opioid antagonistsVAUGHN JASON M·Filed 2007·Application pending·0 cites
- 2262US2008069871A1Hydrophobic abuse deterrent delivery systemVAUGHN JASON M·Filed 2007·Application pending·0 cites
- 2360US9867834B2Non-systemic topical compositions comprising corticosteroidsBANNER LIFE SCIENCES LLC·Filed 2016·Granted Jan 16, 2018·0 cites·30 claims
- 2457US2017360754A1Anticancer compositionsARAGON PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2555US10335375B2Anti-overingestion abuse deterrent compositionsPATHEON SOFTGELS INC·Filed 2018·Granted Jul 2, 2019·0 cites·20 claims
- 2655US2018071278A1Anti-overingestion dosage formsBANNER LIFE SCIENCES LLC·Filed 2017·Application pending·0 cites
- 2746US11903918B2Fumarate ester dosage forms with enhanced gastrointestinal tolerabilityBANNER LIFE SCIENCES LLC·Filed 2021·Granted Feb 20, 2024·0 cites·14 claims
- 2844US2025144057A1Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed stateFLAMEL IRELAND LTD·Filed 2025·Application pending·0 cites
- 2943US2025152546A1Modified release gamma-hydroxybutyrate formulations having improved pharmacokineticsFLAMEL IRELAND LTD·Filed 2025·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →